The Ohio State University | Institution Partners

Keytruda was well tolerated and demonstrated practice-changing responses with potential for a curative approach in a group of patients with advanced endometrial cancer, according to an expert.

A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.